Volta Medical leverages artificial intelligence to revolutionize interventional cardiac electrophysiology. Its cutting-edge software solutions use machine and deep learning algorithms to assist operators during cardiac ablation procedures. Volta’s DNA is to provide physicians with solutions that are user-friendly. Its first medical device, Volta AF-Xplorer, consists of a cue-giving interface designed to facilitate the identification of abnormal electrograms during ablation of complex arrhythmias such as atrial fibrillation. With Volta AF-Xplorer, operators keep their go-to navigation system and catheters. The Volta AF-Xplorer real-time analysis algorithm has been trained on carefully curated databases of annotated intra-cardiac electrograms. The solution may be used as a support to assist electrogram-based atrial fibrillation ablation. Volta AF-Xplorer is CE marked and FDA cleared. Volta Medical is expanding at a fast rate across the globe. Multiple partnerships have been formed with leading centers in Europe and the US.
$38M sweet spot round size
2016
$38M
from 2 investors over 1 rounds
Volta Medical raised $38M on February 5, 2023
Investors: Vensana Capital and + 1 Other investor